Lactobacillus sakei tci147 and method for improving skin condition by using lactobacillus sakei tci147 and/or metabolites thereof
US-2024374505-A1 · Nov 14, 2024 · US
US9730458B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9730458-B2 |
| Application number | US-31224007-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 29, 2007 |
| Priority date | Oct 30, 2006 |
| Publication date | Aug 15, 2017 |
| Grant date | Aug 15, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to the use of an enzymatic method for treating flour, semolina and protein extracts derived from cereals known to stimulate a pathological immune response in patients affected by Celiac Disease (CD). Said treatment drastically reduces or completely eliminates the toxicity of gluten or similar products derived from other cereals. The method uses the catalytic activity of microbial transglutaminase and, in particular, its ability to bind proteins in cereal flour or semolina to an alkylated (C 1 -C 4 ) derivative of lysine. After the treatment said proteins extracted from flour show a substantially lowered immuno-stimulatory activity in celiac patients T lymphocytes.
Opening claim text (preview).
The invention claimed is: 1. A process for obtaining cereal products suitable for gluten-sensitive individuals, the process comprising the steps of: a. providing a cereal product comprising gliadin and gluten, both the gliadin and the gluten having glutamine residues; b. treating the glutamine residues of the gliadin and the gluten with a C 1 -C 4 alkyl ester of lysine in the presence of a transglutaminase, said transglutaminase being an amine γ-glutamyl-transferase EC 2.3.2.13. 2. The method according to claim 1 wherein said transglutaminase is tissue or microbial transglutaminase. 3. The method according to claim 2 wherein said transglutaminase is extractive or is recombinant transglutaminase. 4. The method according to claim 2 wherein said transglutaminase is food-grade. 5. The method according to claim 2 wherein said transglutaminase is microbial transglutaminase. 6. The method according to claim 1 wherein said cereal products comprises gluten and/or gliadin. 7. The method according to claim 1 wherein said cereal product is selected from the group consisting of: oats, wheat, barley or rye. 8. The method according to claim 7 wherein the product is in the form of flour or semolina. 9. The method according to claim 1 wherein said cereal product is selected from the group consisting of: gliadin, avenin, hordein or secalin. 10. The method according to claim 9 wherein said product comprises grain starch. 11. The method according to claim 7 further comprising a step of preparation of a food product. 12. The method of claim 11 wherein said food product is suitable for gluten-sensitive individuals. 13. The method according to claim 1 wherein said alkyl ester is a methyl ester of lysine.
from cereals, flour, bran · CPC title
of vegetable proteins · CPC title
Other treatment of flour or dough before baking, e.g. cooling, irradiating or heating (preservation of flour or dough before baking A23B40/00) · CPC title
Hydrolysates from proteins (hydrolysis of proteins A23J3/30) · CPC title
Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.